How Specialty Pharmacists Can Prepare Patients to Switch to Biosimilars

Marcus H. Snow, MD, of the University of Nebraska Medical Center, discusses how education and counseling can improve the uptake of biosimilars among rheumatologists and patients.

Marcus H. Snow, MD, of the University of Nebraska Medical Center, discusses how education and counseling can improve the uptake of biosimilars among rheumatologists and patients.

Related Videos
sofiko14 / stock.adobe.com
Mammogram scans | Image credit: okrasiuk - stock.adobe.com
WP_7824 / stock.adobe.com
tilialucida / stock.adobe.com
vectorfusionart / stock.adobe.com
Related Content

Expert: Biosimilars May Not Be Cheap, But Are the ‘Very Minimum Helping to Make Cancer Therapies More Accessible Today’

March 14th 2023

Pharmacy Focus: Psychedelic Pharmacy - Understanding Natural vs. Synthetic Psychedelics

January 13th 2023

Biosimilars Have Implications for Pharmacy Practices

March 9th 2023

Pharmacy Focus: Public Health Matters- Celebrating American Pharmacist Month Part 2 with Autumn Zuckerman

October 13th 2022

Affordability of Orphan Drugs Hinges on Global Collaboration

March 6th 2023

FDA Approves Omavaloxolone, the First Drug Indicated for Patients With Friedreich’s Ataxia

March 1st 2023

Expert: Biosimilars May Not Be Cheap, But Are the ‘Very Minimum Helping to Make Cancer Therapies More Accessible Today’

March 14th 2023

Pharmacy Focus: Psychedelic Pharmacy - Understanding Natural vs. Synthetic Psychedelics

January 13th 2023

Biosimilars Have Implications for Pharmacy Practices

March 9th 2023

Pharmacy Focus: Public Health Matters- Celebrating American Pharmacist Month Part 2 with Autumn Zuckerman

October 13th 2022

Affordability of Orphan Drugs Hinges on Global Collaboration

March 6th 2023

FDA Approves Omavaloxolone, the First Drug Indicated for Patients With Friedreich’s Ataxia

March 1st 2023

Expert: Biosimilars May Not Be Cheap, But Are the ‘Very Minimum Helping to Make Cancer Therapies More Accessible Today’

March 14th 2023

Pharmacy Focus: Psychedelic Pharmacy - Understanding Natural vs. Synthetic Psychedelics

January 13th 2023

Biosimilars Have Implications for Pharmacy Practices

March 9th 2023

Pharmacy Focus: Public Health Matters- Celebrating American Pharmacist Month Part 2 with Autumn Zuckerman

October 13th 2022

Affordability of Orphan Drugs Hinges on Global Collaboration

March 6th 2023

FDA Approves Omavaloxolone, the First Drug Indicated for Patients With Friedreich’s Ataxia

March 1st 2023
© 2023 MJH Life Sciences

All rights reserved.